The Latest Developments in Precision Oncology

Precision medicine is a rapidly growing therapeutic area within oncology. Technological innovations have contributed to the refinement of predictive and diagnostic techniques used to tailor therapy for cancer patients. The goal is to not only develop more precise treatments, but...

5 years ago
AI & ML,Oncology,Precision and Personalised Medicine,Biology,News

The Latest Developments in Precision Oncology

Precision medicine is a rapidly growing therapeutic area within oncology. Technological innovations have contributed to the refinement of predictive and diagnostic techniques used to tailor therapy for cancer patients. The goal is to not only develop more precise treatments, but...

5 years ago

Innovations in AI Risk-Based Monitoring in Clinical Research

Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...

5 years ago
Clinical Operations,AI & ML

Innovations in AI Risk-Based Monitoring in Clinical Research

Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...

5 years ago

How Effective is the Automation and Validating of Human Dose Predictive Models?

Dose prediction is a critical part of drug discovery which determines the safety and efficacy of drugs within patients. Dose response predictions are made with preclinical models which quantify pharmacokinetic (PK) behaviour via a number of parameters. Despite the continuous...

5 years ago
R&D,Pharmacovigilance,AI & ML,Biology,News

How Effective is the Automation and Validating of Human Dose Predictive Models?

Dose prediction is a critical part of drug discovery which determines the safety and efficacy of drugs within patients. Dose response predictions are made with preclinical models which quantify pharmacokinetic (PK) behaviour via a number of parameters. Despite the continuous...

5 years ago

An Evaluation of -Omics Technology

Omics technologies have proven to be useful molecular tools across many therapeutic areas in facilitating qualitative and quantitative tissue analysis. Spatially Resolved Transcriptomics (SRT) is an example of -omics technology used in oncology to further investigate how the heterogeneity of...

6 years ago
Oncology,Bioinformatics,Biology

An Evaluation of -Omics Technology

Omics technologies have proven to be useful molecular tools across many therapeutic areas in facilitating qualitative and quantitative tissue analysis. Spatially Resolved Transcriptomics (SRT) is an example of -omics technology used in oncology to further investigate how the heterogeneity of...

6 years ago

How Has COVID Affected Pharmaceutical Manufacturing?

In 2020 the COVID-19 pandemic threw the world into turmoil. The pharmaceutical industry needed to adapt rapidly to meet an increased demand, shifting clinical trials to virtual platforms and of course looking to accelerate COVID vaccine approval. It has become...

6 years ago
Biomanufacturing,Biology,News

How Has COVID Affected Pharmaceutical Manufacturing?

In 2020 the COVID-19 pandemic threw the world into turmoil. The pharmaceutical industry needed to adapt rapidly to meet an increased demand, shifting clinical trials to virtual platforms and of course looking to accelerate COVID vaccine approval. It has become...

6 years ago

The Current Outlook for Investment in Oncology

Oncology alone accounts for one-third of the global clinical pipeline across all therapeutic areas. In 2024, the global oncology therapeutics sales are forecasted to hit $250 billion. As the world’s largest therapeutic area, it is a highly competitive market with...

6 years ago
Investment,Biology,News

The Current Outlook for Investment in Oncology

Oncology alone accounts for one-third of the global clinical pipeline across all therapeutic areas. In 2024, the global oncology therapeutics sales are forecasted to hit $250 billion. As the world’s largest therapeutic area, it is a highly competitive market with...

6 years ago
Previous Page Showing 204 out of 323 Next Page
Working With us

Interested?
Reserve your space